share_log

Alaunos Therapeutics Continues To Explore Potential Strategic Alternatives; Says Has Reduced Its Workforce By Approximately 80% To Date In Order To Streamline Organization And To Maximize Cash Runway

Benzinga ·  Nov 14, 2023 07:34

Alaunos continues to reduce spend and cost-savings measures taken to date are expected to extend its cash runway into the second quarter of 2024.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment